Drugs for treatment of very high blood pressure during pregnancy
Authors:
- 31 July 2013
- journal article
- review article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2013 (7) , CD001449
Abstract
Very high blood pressure during pregnancy poses a serious threat to women and their babies. The aim of antihypertensive therapy is to lower blood pressure quickly but safety, to avoid complications. Antihypertensive drugs lower blood pressure but their comparative effectiveness and safety, and impact on other substantive outcomes is uncertain. To compare different antihypertensive drugs for very high blood pressure during pregnancy. We searched the Cochrane Pregnancy and Childbirth Group Trials Register (9 January 2013). Studies were randomised trials. Participants were women with severe hypertension during pregnancy. Interventions were comparisons of one antihypertensive drug with another. Two review authors independently assessed trials for inclusion and assessed trial quality. Two review authors extracted data and checked them for accuracy. Thirty-five trials (3573 women) with 15 comparisons were included. Women allocated calcium channel blockers were less likely to have persistent high blood pressure compared to those allocated hydralazine (six trials, 313 women; 8% versus 22%; risk ratio (RR) 0.37, 95% confidence interval (CI) 0.21 to 0.66). Ketanserin was associated with more persistent high blood pressure than hydralazine (three trials, 180 women; 27% versus 6%; RR 4.79, 95% CI 1.95 to 11.73), but fewer side-effects (three trials, 120 women; RR 0.32, 95% CI 0.19 to 0.53) and a lower risk of HELLP (haemolysis, elevated liver enzymes and lowered platelets) syndrome (one trial, 44 women; RR 0.20, 95% CI 0.05 to 0.81).Labetalol was associated with a lower risk of hypotension compared to diazoxide (one trial 90 women; RR 0.06, 95% CI 0.00 to 0.99) and a lower risk of caesarean section (RR 0.43, 95% CI 0.18 to 1.02), although both were borderline for statistical significance.Both nimodipine and magnesium sulphate were associated with a high incidence of persistent high blood pressure, but this risk was lower for nimodipine compared to magnesium sulphate (one trial, 1650 women; 47% versus 65%; RR 0.84, 95% CI 0.76 to 0.93). Nimodipine was associated with a lower risk of respiratory difficulties (RR 0.28, 95% CI 0.08 to 0.99), fewer side-effects (RR 0.68, 95% CI 0.55 to 0.85) and less postpartum haemorrhage (RR 0.41, 95% CI 0.18 to 0.92) than magnesium sulphate. Stillbirths and neonatal deaths were not reported.There are insufficient data for reliable conclusions about the comparative effects of any other drugs. Until better evidence is available the choice of antihypertensive should depend on the clinician's experience and familiarity with a particular drug; on what is known about adverse effects; and on women's preferences. Exceptions are nimodipine, magnesium sulphate (although this is indicated for women who require an anticonvulsant for prevention or treatment of eclampsia), diazoxide and ketanserin, which are probably best avoided.Keywords
This publication has 99 references indexed in Scilit:
- Magnesium sulphate and other anticonvulsants for women with pre-eclampsiaCochrane Database of Systematic Reviews, 2010
- Digoxin Immune Fab Treatment for Severe PreeclampsiaAmerican Journal of Perinatology, 2010
- A Randomised, Double-Blinded, Placebo-Controlled Study of the Phosphodiesterase Type 5 Inhibitor Sildenafil for the Treatment of PreeclampsiaHypertension in Pregnancy, 2009
- The Two Stage Model of Preeclampsia: Variations on the ThemePlacenta, 2009
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy2007
- Hyperuricaemia and preeclampsia: is there a pathogenic link?Medical Hypotheses, 2004
- The haemodynamic effects of ketanserin versus dihydralazine in severe early‐onset hypertension in pregnancyBJOG: An International Journal of Obstetrics & Gynaecology, 1998
- Oral nifedipine therapy in the management of severe preeclampsiaInternational Journal of Gynecology & Obstetrics, 1995
- Antihypertensive Drug Effects on Placental Flow Velocity Waveforms in Pregnant Women with Severe HypertensionAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1992
- Effectiveness of Antihypertensive Drugs in the Treatment of Hypertension in PregnancyClinical and Experimental Hypertension. Part B: Hypertension in Pregnancy, 1990